Urgent need for ‘immediate’ solutions to combat drug-resistant infections, warns WHO
Two new WHO reports reveal that while some 50 new antibiotics and 10 biologics are under development, only 32 of the total target WHO-priority pathogens and the majority have very limited benefits when compared to existing antibiotics. “Never has the threat of antimicrobial resistance been more immediate and the need for solutions more urgent”, said WHO Director-General Tedros Adhanom Ghebreyesus.…
Read More
